Brief: Synact Pharma Shares In Directed Issue At Subscription Price Of SEK 16 Per Share
June 4 (Reuters) - SynAct Pharma AB SYNACT.ST: SHARES IN DIRECTED ISSUE ARE ISSUED AT A SUBSCRIPTION PRICE OF SEK 16 PER SHARE CARRIES OUT A DIRECTED SHARE ISSUE OF SEK 37 MILLION AND EXTENDS ITS FINANCIAL RUNWAY TO END OF 2026 SHARES ISSUED AT SUBSCRIPTION PRICE OF SEK 16 PER SHARE DIRECTED ISSUE TO PROVIDE ABOUT SEK 37 MILLION BEFORE COSTS Source text: ID:nMFN77rdT Further company coverage: SYNACT.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development